1. SEPTEMBER 2026

Dadi Oskarsson Appointed Director Supply Chain Operations at Coripharma

Dadi has been appointed Director Supply Chain Operations at Coripharma and will join the company's Executive Management Team.

 

Dadi brings more than 15 years of experience in the pharmaceutical industry, with extensive expertise in supply chain operations, business development, and cross-functional collaboration. Since joining Coripharma in 2022, he has worked on contract manufacturing initiatives and played an increasingly important role in the business development of the company's own-developed products. Throughout his career, Dadi has built strong relationships with international stakeholders, suppliers, and strategic partners, providing him with a broad understanding of the global pharmaceutical value chain and positioning him well for his new role.

 

"It is a tru­ly ex­cit­ing op­por­tu­ni­ty to lead Co­riphar­ma's Sup­ply Chain Op­er­a­tions. I look for­ward to tak­ing on this new role and con­tin­u­ing to build a strong and ef­fi­cient sup­ply chain or­ga­ni­za­tion that sup­ports the com­pa­ny's con­tin­ued growth," says Dadi

 

"It is par­tic­u­lar­ly re­ward­ing to fill such an im­por­tant po­si­tion from with­in our own or­ga­ni­za­tion. It re­flects the strength, ex­per­tise, and ex­pe­ri­ence we have built at Co­riphar­ma and pro­vides an im­por­tant foun­da­tion as we con­tin­ue to grow the com­pa­ny. Dadi pos­sess­es ex­ten­sive knowl­edge and ex­pe­ri­ence in sup­ply chain man­age­ment. Ef­fi­cient and re­li­able de­liv­ery of prod­ucts and ser­vices from sup­pli­ers to cus­tomers is a key dri­ver of Co­riphar­ma's con­tin­ued growth and suc­cess, and I am con­fi­dent that Dadi will play an im­por­tant role in that jour­ney," says Jon­i­na Gud­munds­dót­tir, CEO.

 

Coripharma is a pharmaceutical company specializing in the development, manufacturing, and export of generic medicines. The company currently employs approximately 230 people.

Dadi Oskarsson Appointed Director Supply Chain Operations at Coripharma